Brief: Harrow Health Q2 core EPS USD -0.02
09/08/2023 21:53
Aug 9 (Reuters) - Harrow Health Q2 core EPS USD -0.02. * Q2 EPS USD -0.14 * Q2 gross margin 70% * Q2 core gross margin 78%
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates